Nobivac® NXT FeLV:
The Next Generation of Non-Adjuvanted Protection

***Click Here to Register***

Feline leukemia virus (FeLV) is not a new thing. We have all been talking about, reviewing, diagnosing, and managing FeLV for as long as we have been veterinarians, and the attention we pay to this retrovirus is well-deserved. Infection with FeLV sets the stage for a battle between the cat’s immune system and the virus: with lifelong consequences if the virus manages to integrate into the cat’s DNA.
Safe and effective protection against this pathogen is of paramount importance, and Merck Animal Health’s Nobivac® NXT FeLV brings that protection to the next level with cutting-edge vaccine technology in a non-adjuvanted, 0.5 mL dose with a two year duration of immunity.

In this presentation, learn how RNA particle vaccines are allowing us to protect our feline friends against an old virus in an entirely new way.

Program Agenda:

• A look at feline leukemia virus: what it is, how it works, and what clinical outcomes can occur following exposure of a cat to this retrovirus.
  A review of our diagnostic, therapeutic, and preventative options when it comes to feline leukemia virus.
• An explanation of the unique advantages of RNA particle vaccine technology and the mechanism by which it provides both cell-mediated and antibody-mediated immunity
• Presentation of the data demonstrating the protection provided to our feline patients by Nobivac® NXT FeLV

Learning objectives:
1. Review the pathogenesis of feline leukemia virus and the significance of the clinical outcomes of infection.

2. Be able to easily discuss the importance of feline leukemia testing with pet owners, as well as the importance of vaccination of all kittens and cats less than 1 year of age with feline leukemia vaccine as a core vaccine.

3. Gain familiarity with the historical classes of vaccines used in companion animal medicine and gain an appreciation of how Nobivac® NXT is a novel class.

4. Understand how RNA particle vaccines work to provide both cell-mediated and antibody-mediated immunity, and the unique characteristics of this vaccine class.

5. Learn about Nobivac® NXT FeLV and how this is an innovative and exciting new way to protect our pets from feline leukemia virus.

Speaker: Laura M. Greene, DVM, DACVIM (SAIM)

Bio: Dr. Laura Greene graduated with her DVM from NC State’s College of Veterinary Medicine,
completed a rotating small animal internship at the University of Georgia, and then returned to NC State for her residency in small animal internal medicine. She is a Diplomate of the American College of Veterinary Internal Medicine and spent several years in specialty private practice before joining Merck Animal Health as a Senior Professional Services Veterinarian and member of the Veterinary Insights and Medical Affairs Department. She is published in multiple journals including JAVMA and the Journal of Veterinary Internal Medicine, has spoken both nationally and internationally on topics including infectious disease, immunology, endocrinology, and oncology, and regularly presents continuing education to veterinarians around the country.

In her free time, she enjoys watercolor painting, digital art, and spending time with her family and her Cavalier King Charles Spaniel, Primrose.

Sponsor:

SCVMA and VMBA Present:

Join Us!

For an Evening of Networking With Western U Veterinary Students

You’re invited to attend our upcoming student networking event, where you’ll have the opportunity to connect with veterinary students, share your journey, answer questions, and help shape the next generation of veterinarians!

Your presence makes a difference- we hope to see you there!

Thursday August 7, 2025

5:30pm-7:30pm

Location:

Cosmo Restobar

197 E 2nd Street Pomona

   **To RSVP Click Here**

Feline Diabetes: A New Chapter

***Click Here to Register***

In this session, we will review our current understanding of feline diabetes mellitus and discuss the impacts of insulin resistance and glucose toxicity on pancreatic function. A brief summary of previous efforts to manage diabetic cats with oral medications will be followed by an overview of the sodium-glucose cotransporter 2 (SGLT2) inhibitors and their effects in this species. Velagliflozin oral solution will be introduced and insights shared regarding appropriate patient selection, monitoring, and troubleshooting. Information on when to consider a switch to insulin and how to make this change will be provided.

Speaker: Dr. Audrey Cook, BVM&S, MSc Vet Ed, MRCVS, DACVIM, DECVIM, DABVP, Professor of Small Animal Internal Medicine, Texas A&M University

Bio: Dr. Audrey Cook is a graduate of the University of Edinburgh in Scotland. She completed her internship at NC State University and her Residency in Small Animal Internal Medicine at the University of California, Davis. Dr. Cook is a diplomate of both the American and European Colleges of Veterinary Internal Medicine and is recognized as a specialist in feline practice by the American Board of Veterinary Practitioners.

After a decade in private referral practice, Dr. Cook joined the faculty at Texas A&M University. She is now a Professor of Small Animal Internal Medicine and Co-Chief of the Medicine Section, with particular interests in endocrinology, gastroenterology, and interventional radiology.

Sponsor:

Introducing a Quantum Leap: BRAVECTO® Quantum

***Click Here to RSVP***

Join Merck Animal Health’s Dr. Sumeet Gupta in reviewing the latest innovations to come to companion animal medicine. An introduction to BRAVECTO® Quantum (fluralaner for extended-release injectable suspension), a new product for dogs labeled to kill fleas and ticks for up to 12 months.

The presentation will discuss the risks that fleas and ticks pose to dogs, and the gap in compliance associated with existing parasiticide options. The presentation will then introduce learners to BRAVECTO® Quantum, a novel approach to killing ectoparasites and the prevention of the diseases they transmit. The introduction to the product will center on handling and administration, as well as salient safety and efficacy data related to BRAVECTO® Quantum.

Speaker: Dr. Sumeet Gupta, DVM

Bio: Dr. Sumeet Gupta joined Merck Animal Health’s Companion Animal team in Southern California as a Professional Services Veterinarian in July 2024, following three rewarding years in private practice in Honolulu. With expertise in practice management, emergency care, and exotic animal medicine, he is passionate about helping veterinarians enhance their practice and improve patient outcomes. A graduate of Ohio State’s Veterinary College, Dr. Gupta first started as an Intern at VCA West LA, then moved into emergency overnight practice, eventually becoming Medical Director for several years. After serving as a PSV for IDEXX Labs during the pandemic in NYC and transitioning to General Practice in Hawai’i, he has returned to Southern California with his husband, Manwé, and their dog, “Obiwan Kenobi”

Sponsor:

Lymphoma:

Find it Early, Fight it Early

***Click Here to RSVP***

The revolutionary IDEXX Cancer Dx testing panel: Give your patients an edge in the fight against canine cancer.

IDEXX Cancer Dx™ testing has arrived. And according to early data, it can detect lymphoma even before clinical signs are present. IDEXX Cancer Dx testing can be affordably and easily incorporated into testing for sick pets and IDEXX Preventive Care profiles for at-risk dogs, and it provides actionable insights to inform next steps.

• It can be hard to find lymphoma early. IDEXX Cancer Dx testing is your GPS.Cancer is a leading cause of death in canines, with 1 in 4 dogs in the U.S. expected to be diagnosed with cancer in their lifetime. Veterinarians field nearly 750,000 questions annually from pet owners about cancer testing-and now, you have an answer.
• Results that can give you time to take action. And guidance to know which action to take.Timing is only half the battle. That’s why we offer actionable, oncologist-recommended guidance to inform your next steps. Get personalized, comprehensive support from IDEXX Medical Consulting Services. In many cases, B-cell vs. T-cell phenotype classification will be provided with positive results at no additional cost.
• A new recruit in the war against cancer.The revolutionary, proprietary technology behind IDEXX Cancer Dx testing detects a circulating biomarker specific to canine lymphoma. In the coming years, we plan to add detection of more of the most common canine cancers.

Combined with our leadership in key cancer diagnostic categories, like pathology and imaging, we can work together to create a better future for all pets.

Learn more about IDEXX Cancer Dx testing and our entire oncology portfolio at idexx.com/cancerdx

Speaker: Dr. Joy Bunkley, BS, DVM

Bio: Dr. Bunkley was born and raised in Los Angeles, CA. After high school she left home to pursue her childhood dream of becoming a veterinarian. She ventured to the Southeast for her studies to obtain a Bachelor’s Degree in Animal and Poultry Science and a Doctorate in Veterinary Medicine from Tuskegee University. After Veterinary school she decided to stay in the south and moved to Duluth, Georgia. There she practiced Small Animal Medicine as an associate doctor for 2 years. Dr. Bunkley later became Chief of Staff at a corporate Small Animal Practice in Norcross, Georgia. After over 5 years in GA she decided to move back home to Los Angeles and continued her work as a as a small animal veterinarian . Dr. Bunkley ventured into shelter medicine at a local shelter in Los Angeles. There she practiced for 2 years before moving to the prestigious company IDEXX as a Professional Services Veterinarian for the Los Angeles region. Overall, she has a strong track record of leadership, medical and surgical expertise, and financial acumen. Currently, Dr. Bunkley resides in Long Beach, CA. She is a proud pet parent to Duke, a 4 yr old lovable Rottweiler. In her spare time, Dr. Bunkley enjoys going to the beach, traveling, listening to live music, and reading.

Sponsor:

SCVMA and MiDog Present:

From Clinic to Genome:

Collaborative Discovery of a Novel Castellaniella Species in a Fatal Canine Infection

Free Webinar!

Approved for one hour California Statutory CEU

Wednesday, August 13, 2025
12:00 – 1:00 PM PT

**Click Here to Register**

In this compelling case-based webinar, Dr. Lina Crespo Bilahalva and Dr. Mark Yacoub, Microbiome Scientist I at MiDOG, present a groundbreaking investigation that led to the identification of a previously undescribed bacterial species in a fatal canine respiratory case.

This session will walk attendees through the full diagnostic journey — from initial clinical presentation and conventional test limitations to the transformative role of next-generation sequencing (NGS) and whole-genome analysis. The webinar showcases how collaboration between clinical practitioners and molecular scientists can unlock hidden pathogens and deliver unprecedented microbial insights.

What You’ll Learn:

• The clinical context and diagnostic challenges surrounding the case
• How MiDOG’s All-in-One Test and Whole Genome Sequencing revealed a novel Castellaniella species
• Insights into the genomic features and clinical significance of this new pathogen
• The importance of interdisciplinary collaboration in advancing infectious disease diagnostics
• Practical applications of NGS in veterinary medicine for complex or unresolved infections

Who Should Attend:
This webinar is designed for veterinarians, microbiologists, veterinary specialists, researchers, and anyone interested in the future of molecular diagnostics in companion animal care.

 Presented By:

DR. LINA CRESPO BILHALVA, DVM, MSc, PhD | PhD Clinical Pathology Resident, Cummings School of Veterinary Medicine at Tufts University

and

DR. MARK YACOUB, PhD | MICROBIOME SCIENTIST I- MiDog Animal Diagnostics

Sponsored By:

Genitourinary Neoplasia

**Click Here to RSVP**

In this lecture, we will focus on urinary system tumors (urothelial carcinoma), prostatic carcinomas, and mammary tumors in dogs versus cats.

Speaker: Dr. David Heller, DVM, DACVIM- Oncology

Sponsor:

The Mysterious FIP:
Diagnosis, Treatment, and Management of Complicated Cases, Relapses, and Comorbidities in Cats with FIP

***Click Here to Register***

Speaker: Petra Černá, PhD, DACVIM (SAIM), MANZCVS (Medicine of Cats), CertAVP (SAM-F), MRCVS, AFHEA, AdvCertFB

Bio: Dr. Černá is an ACVIM diplomate in small animal internal medicine. She graduated from the University of Veterinary Sciences in the Czech Republic in 2018 where she also obtained her PhD in 2023. After completing two internships in the UK, she completed Small Animal Internal Medicine Residency at Colorado State University, USA in 2023. Dr. Černá was awarded the RCVS Certificate in Advanced Veterinary Practice in Feline Medicine and also gained the Membership of the Australian and New Zealand College of Veterinary Scientists in the Medicine of Cats. She was also awarded the ISFM Advanced Certificate in Feline Behaviour with Distinction. Dr. Černá has particular interest in feline medicine and is currently a PhD candidate at Colorado State University in Feline Infectious Peritonitis (FIP).

Sponsor:

Orthopedics and Osteoarthritis

**Click Here to RSVP**

Speaker: Dr. Denis Marcellin-Little, DVM, DACVS- Dept. Chair (Interim) and Professor Surgical & Radiological Sciences, UC Davis

Sponsor:

Hill’s Presents:

Oldies But Goodies:
A Senior Pet Focused Symposium

Topics include Canine Osteoarthritis, Cognitive Dysfunction, and Nutrition in the Aging Pet

**more details coming soon**

**Click Here to Register**

Approved for 3 hours of California Statutorily Approved CEU

Limited to 120 Attendees

FREE for SCVMA members before 8/13/2025

$75.00 for non-members before 8/13/2025

$75.00 for everyone after 8/13/2025

**Discounted park tickets are available for purchase for $52.00 each for attendees only**

Click Here to Purchase Discounted Knott’s Theme Park Tickets